The new guideline replaces 2017 guidance after new evidence from multiple large trials emerged, indicating comparable outcomes with partial and whole breast radiation.
/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRTâ„¢, announced today that it has.
/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRTâ„¢, announced today that it has.